Bioarray Therapeutics

About:

Bioarray Therapeutics is a biotech company that is committed to transforming cancer treatment decisions and outcomes using gene profiling.

Website: http://bioarray.us/

Twitter/X: bioarraymdx

Top Investors: Connecticut Innovations, MassChallenge, Quark Venture, GF Securities

Description:

BIOARRAY's Therapeutics, Inc. (BIOARRAY) is a privately held start up biotechnology company founded in 2009 in Boston, MA. BIOARRAY is developing proprietary predictive diagnostic tests, based on cancer genes (markers), to choose to the most efficacious treatment for cancer patients beforehand, rather than the trial and error approach currently used.

Total Funding Amount:

$5.47M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)bioarray.us

Founders:

Katherine Martin, Marcia Fournier

Number of Employees:

1-10

Last Funding Date:

2017-10-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai